SCHEMBL68185

SCHEMBL68185

Oc1ccc(Oc2ccccc2O)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.60
NR1H2 P55055 1/20 0.60
BAX Q07812 1/20 0.60
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
TP53 P04637 1/20 0.48
TSHR P16473 1/20 0.48
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
AR P10275 1/20 0.45
JAK2 O60674 1/20 0.45
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29024081 0.93 CA2 (0.54) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL9344917 0.91 TSHR (0.52) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL4211500 0.88 LTA4H (0.68) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL5528855 0.86 LTA4H (0.60) LTA4HNR1H2BAXCA1CA2
SCHEMBL8560469 0.86 CA2 (0.48) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL29833728 0.86 CA2 (0.48) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL9483870 0.86 LTA4H (0.73) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL29449754 0.86 TTR (0.57) LTA4HNR1H2BAXKMT2ACA1
SCHEMBL260447 0.86 TTR (0.57) LTA4HNR1H2BAXKMT2ACA1
SCHEMBL5401074 0.84 MEN1 (0.54) LTA4HNR1H2BAXMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330359-A1 CLEANING COMPOSITIONS INCLUDING ENZYME AND DYE CONTROL AGENT The Procter & Gamble Company (US) 2018-06-06 EP claimed
EP-3330354-A1 CLEANING COMPOSITIONS INCLUDING ENZYME AND DYE CONTROL AGENT The Procter & Gamble Company (US) 2018-06-06 EP claimed
EP-3083920-A1 COLOR-SAFE DETERGENTS Henkel AG & Co. KGaA (DE) 2016-10-26 EP claimed
EP-3083919-A1 ANTI-REDEPOSITION DETERGENTS Henkel AG & Co. KGaA (DE) 2016-10-26 EP claimed
WO-2015091174-A1 ANTI-REDEPOSITION DETERGENTS HENKEL AG & CO. KGAA (DE) 2015-06-25 WO claimed
WO-2015091176-A1 COLOR-SAFE DETERGENTS HENKEL AG & CO. KGAA (DE) 2015-06-25 WO claimed
WO-2015091175-A1 ANTI-REDEPOSITION DETERGENTS HENKEL AG & CO. KGAA (DE) 2015-06-25 WO claimed
US-20110013934-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR MITSUBISHI CHEMICAL CORPORATION (JP) 2011-01-20 US claimed
US-20090047589-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR MITSUBISHI CHEMICAL CORPORATION (JP) 2009-02-19 US claimed
EP-1770447-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE BODY Mitsubishi Chemical Corporation (JP) 2007-04-04 EP claimed
WO-2003002080-A1 COMPOSITIONS CONTAINING A DERIVATIVE OF HYDROXYDIPHENYL ETHER INHIBITING THE DEVELOPMENT OF BODY ODOURS L'OREAL (FR) 2003-01-09 WO claimed
WO-2003002078-A1 COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS L'OREAL (FR) 2003-01-09 WO claimed
WO-2003002081-A1 COMPOSITION COMPRISING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING THE DEVELOPMENT OF BODY ODOURS L'OREAL (FR) 2003-01-09 WO claimed
WO-2003002079-A1 COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS L'OREAL (FR) 2003-01-09 WO claimed
WO-2003002072-A1 COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS L'ORÉAL (FR) 2003-01-09 WO claimed
US-4582944-A Process for producing hydroxydiphenyl ethers MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1986-04-15 US claimed
JP-1228884-A None JP disclosed
US-20260085145-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED ARTICLE DAINIPPON INK & CHEMICALS (JP) 2026-03-26 US disclosed
EP-0320346-A2 Process for preparing hydroxylated aromatic derivatives by way of the Bayer-Villiger reaction RHONE-POULENC CHIMIE (FR) 1989-06-14 EP disclosed
US-3933957-A Process for producing shaped articles from an acetylenic polymer GENERAL ELECTRIC COMPANY (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085145-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED ARTICLE MAT1A, CAPZA1, CDH1 LTA4H 663/4885NR1H2 3144/4885BAX 3956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.